(9 years, 2 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
I congratulate the hon. Member for Newport West (Paul Flynn) on bringing the petition to the House and all those who signed it. That is probably the last time I will remember the name of a constituency; I have not yet got to grips with the constituencies, so I will probably point a lot.
It is clear from the petition that cannabis and its production, use and legislation is an important issue to the people of the United Kingdom. I received an email from a constituent yesterday informing me that more people signed the petition in Scotland than anywhere else, and that Glasgow was the city with the highest number of signatories, with my own constituency having one of the highest rates. For that reason, and because I am the Scottish National party spokesperson on civil liberties, I am pleased to contribute to the debate.
The frustration that the signatories to the petition must feel is that, although the issue evokes strong emotions in different quarters, there is no settled demand for any specific legislative change. Even today, most of the speakers, however they feel about the matter, acknowledged the other side of the debate. I do not envy those who have to make the decision, but I echo everyone else’s calls for much more research, so that we can get to the bottom of the argument.
The debate also reflects some of the idiosyncrasies of the current devolutionary settlement, in that control of drugs is reserved to the UK Parliament under the Misuse of Drugs Act 1971, but the treatment and prevention of drug problems is devolved to the Scottish Government. That is an unhelpful division in a policy area that is too important for there to be a fragmented approach, but it also illustrates that there are a number of facets to the issue: harm reduction and public health on the one hand and legality and criminalisation on the other. There is a strong argument—I have heard this a couple of times today—that public health should be the focus when considering drug and alcohol use and misuse. The right hon. Member for some constituency, which I am sure is wonderful—
The right hon. Gentleman made the strong argument that the Department of Health should consider the issue, not the Ministry of Justice. In Wales they do things differently—health is devolved to Wales. They have centres there where they carry out tests so that those who choose to use illegal substances can find out what is in them. I am interested in hearing more about the impact of those centres.
Taking a multifaceted approach stands in contrast to the often ill-informed populism that, as many hon. Members, including the hon. Member for Newport West, have said, often decided policy under all Governments in the past. There is a need, therefore, for much more research and more definite conclusions, to remove the debate from the realms of both an ill-informed populism —on both sides of the debate at times—or an abstract legalism.
Many hon. Members will know of the real difficulties that criminal records cause people in the poorest communities. Those communities are also often the ones most heavily blighted by the antisocial use of drugs. At this point, I want to do a “bit of a Jeremy Corbyn” and provide a voice for my constituents because, like most hon. Members , I have had many emails on the issue. I will quote just a couple of them, because they have asked me to be their voice here today, although they have differing views on the matter. Drew from Robroyston says:
“I understand arguments on both sides but it is hypocritical that we freely sell and consume substances such as alcohol and tobacco but prosecute those who choose to ingest less harmful drugs.”
Caroline, however, says:
“My brother was managing his schizophrenia until he started cannabis.”
William asks me:
“If the Misuse of Drugs Act is there to prevent social harm and alcohol and tobacco aren’t illegal, why am I made to be a criminal for smoking cannabis?”
Another constituent says:
“The fact that alcohol is legal is not an argument for also legalising cannabis. If we were considering legalising alcohol today, would we?”
The petitioners may not get all they are campaigning for today—they may; I have no idea what the Minister will say—but they need to know that their arguments are being listened to, and the best way to achieve that is to commit to researching the issues properly. Those opposed to the petition would surely be satisfied by that, because they believe that research will back up their arguments. It is a win-win for the Government, and I urge the Minister to commit to that research today.
One of the clearest things we know from the research that has already been done is how much work remains. The effects of alcohol and tobacco are well documented in our society, and the Scottish Government continue, via their minimum pricing regulation, to stand up for public health in the face of pressure from the industry and, sometimes, the public. However, the health effects of cannabis at a societal level, its relation to other drugs including tobacco and its relationship, causal or otherwise, with mental health problems require further study.
A very close associate of mine has bipolar. She was a regular user of cannabis. She asked two different psychiatrists, “Did that make it worse?”, and one said yes and the other said no. She asked them whether it caused her bipolar, and one said, “Possibly”, and the other said, “You possibly started to use it to cope with the effects of an undiagnosed condition.” That is the problem. I have heard a couple of Members say that there is conclusive evidence, but there is no conclusive evidence that cannabis does not exacerbate pre-existing mental health problems. Anyone with any experience of mental illness would never support anything that would exacerbate or cause psychotic episodes. Another argument that is put is on whether alcohol exacerbates mental health conditions. If research is done and it is found that cannabis has a serious impact on people’s mental health, that would be a strong argument against its legalisation.
On the other hand, we have to look at physical conditions. We have heard much today about medicinal cannabis. I was emailed by Michelle Anne; I think she probably emailed everyone. She was demonstrating outside today, and she is possibly in the Public Gallery. She described the physical symptoms of some of her conditions. I cannot read all the email out, but she talked about waking up and how before she moves, she has to fight spasms, cramps and electric shocks. She described it as like being
“thrown into a bed of nettles”.
She spoke movingly about how, as a result of her using what she referred to as organic, well-grown, cured cannabis, she now feels happy, sleepy and hungry—all welcome benefits.
Although we have heard arguments in favour of legalisation, it is clear that that is not a panacea. The evidence from the US states that have proceeded with decriminalisation indicates a variety of outcomes. All parties would probably benefit from a continued study of those jurisdictions and our European neighbours to inform policy in this country. It is surely a gift to us that we do not have to rely on a debate to come to a conclusion; we have evidence from around the world and other countries willing to share it with us. As the hon. Member for Newport West said, they have done the work for us, so let us use it.
There are clear arguments against legalisation, but the House would do well to heed some of the real problems associated with the policy as it stands. Those from our poorest communities and from black and minority ethnic communities are affected most severely by the criminalisation policy. The right hon. Member for Hitchin and Harpenden (Mr Lilley) talked about morality, but I would put it another way: there is a snobbish attitude to cannabis as compared with other drugs. As other Members have said, it would appear from various media reports that those of a middle to upper-class background can partake in illicit substances in their university days without ever jeopardising their future careers. However, for many people from a working-class background, a drugs-related conviction, no matter how minor, can have a devastating impact on their life chances in terms of employment.
Let us also consider one group of primarily black and minority ethnic users—Rastafarians. Their use of cannabis is part of their religious and spiritual beliefs. I am probably the only speaker here today—Members can prove me wrong if they like—whose partner is a Rastafarian. I might get shot down in flames for this, but he is probably the only Rastafarian who has never used cannabis. It is not compulsory for Rastafarians to use cannabis, but it is part of their spiritual outlook. He has asked, “If I choose to use cannabis because it is part of my religious beliefs, where are my civil liberties if that criminalises me?”
I end by making one final point. The international context of our drug legislation must be considered. The UN drug conventions are all more than a quarter of a century old, and there is growing anticipation ahead of the international discussions in 2016, which will be informed by a far broader base of evidence accumulated in the interim period. It is noteworthy that some of the countries that requested that the discussions be brought forward are very much at the forefront of what was once called the war on drugs. The Government should ensure that the United Kingdom participates fully in the UN discussions on drugs policy. That will allow us to act responsibly on the international stage, using UK evidence to inform international approaches and utilising the latest international research to influence policy here on these islands.